| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
PHARMACOKINETICS AND PHARMACODYNAMICS |
From the Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan (Dr. Tashiro, Dr. Sakurada, Dr. Iwabuchi, Dr. Mochizuki, M. Kato, M. Aoki, Dr. Yanai); the Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan (Dr. Funaki, Dr. Itoh, Dr. Iwata); and the Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, Maryland (Dr. Wong).
Histamine H1-receptor (H1R) antagonists, or antihistamines, often induce sedative side effects when used for the treatment of allergic disorders. This study compared the sedative profiles of the second-generation antihistamines, fexofenadine and cetirizine, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of histamine H1-receptor occupancy (H1RO) in the brain. Subjective sleepiness and psychomotor performance were measured in 20 healthy Japanese volunteers at baseline and 90 min after administration of fexofenadine 120 mg or cetirizine 20 mg in a double-blind, placebo-controlled crossover study. Hydroxyzine 30 mg was included as a positive control. H1RO was measured using positron emission tomography (PET) with 11C-doxepin in 12 of the 20 subjects, and a further 11 volunteers were recruited to act as controls. In psychomotor tests, fexofenadine was not significantly different from placebo and significantly less impairing than cetirizine on some tasks, as well as significantly less impairing than hydroxyzine on all tasks. For subjective sleepiness, fexofenadine was not significantly different from placebo, whereas cetirizine showed a trend toward increased sleepiness compared with fexofenadine and placebo. H1RO was negligible with fexofenadine (-0.1%) but moderately high with cetirizine (26.0%). In conclusion, fexofenadine 120 mg is distinguishable from cetirizine 20 mg, as assessed by H1RO and psychomotor testing.
Key Words: Fexofenadine • cetirizine • histamine H1-receptor (H1R) • sleepiness • psychomotor performance • positron emission tomography (PET) • second-generation antihistamine • H1-receptor occupancy (H1RO)
Address for reprints: Professor Kazuhiko Yanai, Department of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Senda, N. Kubo, K. Adachi, Y. Ikari, K. Matsumoto, K. Shimizu, and H. Tominaga Cerebral Histamine H1 Receptor Binding Potential Measured with PET Under a Test Dose of Olopatadine, an Antihistamine, Is Reduced After Repeated Administration of Olopatadine J. Nucl. Med., June 1, 2009; 50(6): 887 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gupta, P. Chatelain, R. Massingham, E. N. Jonsson, and M. Hammarlund-Udenaes BRAIN DISTRIBUTION OF CETIRIZINE ENANTIOMERS: COMPARISON OF THREE DIFFERENT TISSUE-TO-PLASMA PARTITION COEFFICIENTS: Kp, Kp,u, AND Kp,uu Drug Metab. Dispos., February 1, 2006; 34(2): 318 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Meltzer Evaluation of the Optimal Oral Antihistamine for Patients With Allergic Rhinitis Mayo Clin. Proc., September 1, 2005; 80(9): 1170 - 1176. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
